Simulations Plus Says Acquisition Target Has Chosen a Rival Suitor

May 22, 2009

A Simulations Plus official said that the firm was "in competition with another suitor, and although the offers were essentially equal, the company we wanted to acquire decided to pursue the other offer."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.

In this issue of BioInform

Young Investigator Profile

Martin Beck

European Molecular Biology Laborator
Group Leader, Structural and Computational Biology Unit

Macromolecular Assemblies

Martin Beck's research group at EMBL combines biochemical approaches, proteomics and cryo-electron microscopy to study the structure and function of large macromolecular assemblies. The end goals of this work include developing integrated workflows for structure determination of large macromolecular assemblies such as the nuclear pore complex, elucidation of their function through real-time imaging, and ultimately revealing the steps of their assembly and disassembly process.
Blog

Intel's Energy Checker SDK

Intel's new Energy Checker SDK allows users to match software function to the energy it uses.

March 10, 2010

Researchers and Online Journals

Martin Fenner at Gobbledygook looks into studies of how researchers use online journals.

March 10, 2010

Can Blogging Damage Your Career?

A blogger asks "Do scientists hate scientists who talk to the public?"

March 10, 2010

Bad Times in the Bay Area

Exelixis lays off 270 people.

March 10, 2010
Papers of Note

PTB Proteins Induce RNA Looping
Lamichhane, Daubner et al., PNAS
Researchers in the US and Switzerland report that polypyrimidine tract-binding proteins induce RNA looping ― a finding they deduced using FRET, NMR spectroscopy, and in vivo splicing data. They show that two PTB RNA recognition motifs can bind two distant pyrimidine tracts, bringing their 5' and 3' ends in close proximity, thus inducing loop formation.

Aβ as an Antimicrobial Peptide
Soscia, Kirby et al., PLoS ONE
A team of researchers describe the amyloid β-protein as capable of functioning as an antimicrobial peptide in vitro. Their examinations indicate that Aβ, thought to be a key mediator of Alzheimer's disease pathology, demonstrates antimicrobial activity against eight common microorganisms, and may perform this function in the innate immune system ― a finding that contrasts with the current perception of Aβ-mediated pathology.
People on the Move

Adrian Dillon will resign from his job as executive VP of finance and administration and CFO of Agilent Technologies to become chief financial and administrative officer at Skype. He will be replaced at the beginning of April by Didier Hirsch, who currently is VP of corporate controllership and taxes and who will serve as acting CFO.

Pacific Biosciences last week appointed Susan Barnes as its first chief financial officer.

She formerly was senior VP of finance and CFO of Intuitive Surgical and previously served as managing director of the private equity group at Jeffries & Company, among other positions.

Joel McComb is leaving his post as senior VP and GM of Illumina's Life Sciences business to become COO at Synthetic Genomics. McComb will depart Illumina and take on the new position at SGI, where he will report to founder and CEO J. Craig Venter, effective March 1.
Upcoming Events

Conferences, Meetings & Deadlines

NHGRI Advanced Sequencing Technology Development Workshop
Mar. 10-11 / Chapel Hill, NC
National Human Genome Research Center, National Institutes of Health

Neuronal Circuits
Mar. 10-13 / Cold Spring Harbor, NY
CSHL

PTEN Pathways & Targets
Mar. 16-20 / Cold Spring Harbor, NY
CSHL

The Complex Life of mRNA: From Synthesis to Decay
Mar. 18-19 / Heidelberg, Germany
EMBL

Perspectives in Clinical Proteomics
Mar. 18-19 / Hinxton, UK
EMBL-EBI-Wellcome Trust

Abstract & Registration Deadlines

more

Science
A research team has published a proof-of-principle metagenomics study using short read sequencing to catalog and characterize microbial genes present in the human gut, offering insights into the microbial communities colonizing the gut.
Business
Life Technologies, the Translational Genomics Research Institute, and US Oncology are collaborating on a sequencing study aimed at determining whether cancer genome sequencing can help guide individual treatments.
Funding
The National Human Genome Research Institute would receive $534 million under the White House's proposed $32.2 billion budget for the National Institutes of Health for Fiscal Year 2011, up $18 million over the 2010 appropriation.
Genome Technology Magazine
GenomeWeb now has job listings! Check them out, or post your own for free.

Search

Simulations Plus Says Acquisition Target Has Chosen a Rival Suitor

Related Stories

In this issue of BioInform

Young Investigator Profile

Blog

Papers of Note

People on the Move

Upcoming Events

Science

Business

Funding

Genome Technology Magazine

TechGuides Listings

Poll